|
|
|
German |
English |
|
10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-on [EU] |
10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-one | ![](/pics/v.png) |
|
10H-Dibenzo[b, e]thiopyran [EU] |
10H-dibenzo[b,e]thiin | ![](/pics/v.png) |
|
11-Amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepin-hydrochlorid [EU] |
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride | ![](/pics/v.png) |
|
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride [EU] |
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride | ![](/pics/v.png) |
|
11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepindihydrochlorid (CAS RN 111974-74-4) [EU] |
11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride (CAS RN 111974-74-4) | ![](/pics/v.png) |
|
2,4,8,10-Tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxid, Natriumsalz [EU] |
2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxide, sodium salt | ![](/pics/v.png) |
|
3-(5H-Dibenzo[a,d]cyclohepten-5-ylpropyl)dimethylammoniumchlorid [EU] |
3-(5H-dibenzo[a,d]cyclohepten-5-ylpropyl)dimethylammonium chloride | ![](/pics/v.png) |
|
4-(5H-Dibenzo[a,d]cyclohepten-5-yl)piperidin [EU] |
4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine | ![](/pics/v.png) |
|
5-(1-Methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-olhydrochlorid [EU] |
5-(1-methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-ol hydrochloride | ![](/pics/v.png) |
|
5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]chinolin-10,11-diol (Apomorphin) und seine Salze [EU] |
Apomorphine ((R) 5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol) and its salts | ![](/pics/v.png) |
|
5H-Dibenzo[a,d]cyclohepten-5-on [EU] |
5H-dibenzo[a,d]cyclohepten-5-one | ![](/pics/v.png) |
|
(6aR)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de, g]chinolin-10,11-diol oder -apomorphin [EU] |
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol or apomorphine | ![](/pics/v.png) |
|
8-Chlor-5,10-dihydro-11H-dibenzo[b,e] [1,4]diazepin-11-on (CAS RN 50892-62-1) [EU] |
8-Chloro-5,10-dihydro-11H-dibenzo [b,e] [1,4]diazepin-11-one (CAS RN 50892-62-1) | ![](/pics/v.png) |
|
8-Chlor-5,10-dihydro-11H-dibenzo[b,e] [1,4]diazepin-11-on [EU] |
8-Chloro-5,10-dihydro-11H-dibenzo [b,e] [1,4]diazepin-11-one | ![](/pics/v.png) |
|
8-Chlor-5-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl)-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b, e][1,4]diazepin [EU] |
8-chloro-5-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl)-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine | ![](/pics/v.png) |
|
Ablagerung von Dibenzo(a,h)anthracen [EU] |
Dibenzo(a,h)anthracene deposition | ![](/pics/v.png) |
|
Abschnitt V Zeile 1, Dioxine [Summe aus polychlorierten Dibenzo-para-Dioxinen (PCDD) und polychlorierten Dibenzofuranen (PCDF), ausgedrückt in Toxizitätsäquivalenten der Weltgesundheitsorganisation (WHO) unter Verwendung der WHO-TEF (Toxizitätsäquivalenzfaktoren), 2005], erhält folgende Fassung: [EU] |
Row 1 of Section V, Dioxins [sum of polychlorinated dibenzo-para-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) expressed in World Health Organisation (WHO) toxic equivalents, using the WHO-TEFs (toxic equivalency factors, 2005)], is replaced by the following: | ![](/pics/v.png) |
|
alle Isomere von polychlorierten Dibenzodioxinen [EU] |
any congenor of polychlorinated dibenzo-dioxin | ![](/pics/v.png) |
|
alle Isomere von polychlorierten Dibenzofuranen [EU] |
any congenor of polychlorinated dibenzo-furan | ![](/pics/v.png) |
|
Äquivalenzfaktoren für Dibenzo-p-Dioxine und Dibenzofurane [EU] |
Equivalence factors for dibenzo-p-dioxins and dibenzofurans | ![](/pics/v.png) |
More results ![>>>](/pics/aopen.png)
|
The example sentences [G] were kindly provided by the Goethe Institute. Sentences marked by [EU] derived from DGT Multilingual Translation Memory. The European Commission retains ownership of the copyright in the original data. |
No guarantee of accuracy or completeness!
©TU Chemnitz, 2006-2024
|
|
|
|